206 related articles for article (PubMed ID: 32307223)
1. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
Jiang H; Su H; Zhang C; Liu X; Li R; Zhong N; Zhao M
Eur Neuropsychopharmacol; 2020 Jun; 35():136-137. PubMed ID: 32307223
[No Abstract] [Full Text] [Related]
2. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
3. Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
Krawczyk N; Fingerhood MI; Agus D
J Subst Abuse Treat; 2020 Oct; 117():108074. PubMed ID: 32680610
[No Abstract] [Full Text] [Related]
4. Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).
Leppla IE; Gross MS
J Addict Med; 2020; 14(4):e1-e3. PubMed ID: 32412931
[TBL] [Abstract][Full Text] [Related]
5. Opioid Use Disorder and COVID-19: Crashing of the Crises.
Khatri UG; Perrone J
J Addict Med; 2020; 14(4):e6-e7. PubMed ID: 32404651
[TBL] [Abstract][Full Text] [Related]
6. President's message: Will COVID-19 have a lasting impact on opioid treatment program regulations?
Kmiec J
J Addict Dis; 2020; 38(3):239-240. PubMed ID: 32718223
[No Abstract] [Full Text] [Related]
7. Opioids: The Forgotten Epidemic?
Price S
Tex Med; 2020 Oct; 116(10):32-35. PubMed ID: 33126270
[TBL] [Abstract][Full Text] [Related]
8. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Cochran G; Bruneau J; Cox N; Gordon AJ
Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
[TBL] [Abstract][Full Text] [Related]
9. The model of epidemic (COVID-19) prevention and control in rural of China.
Fu B; Fu X
Crit Care; 2020 Apr; 24(1):146. PubMed ID: 32290856
[No Abstract] [Full Text] [Related]
10. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
Crowley D; Delargy I
Harm Reduct J; 2020 Jul; 17(1):49. PubMed ID: 32680520
[TBL] [Abstract][Full Text] [Related]
11. Challenges and Lessons for Managing Glaucoma during COVID-19 Pandemic: Perspectives from Asia.
Husain R; Zhang X; Aung T
Ophthalmology; 2020 Sep; 127(9):e63-e64. PubMed ID: 32479858
[No Abstract] [Full Text] [Related]
12. Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?
Trujols J; Larrabeiti A; Sànchez O; Madrid M; De Andrés S; Duran-Sindreu S
J Subst Abuse Treat; 2020 Dec; 119():108154. PubMed ID: 33032860
[TBL] [Abstract][Full Text] [Related]
13. Thanks to all medical workers fighting against COVID-19.
Chen XP
Front Med; 2020 Apr; 14(2):249-250. PubMed ID: 32329010
[No Abstract] [Full Text] [Related]
14. [The importance of strengthening the ability of fundamental disease prevention and control system from the perspective of the epidemic situation of anti COVID-19].
Wang M
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 May; 54(5):480-483. PubMed ID: 32107911
[TBL] [Abstract][Full Text] [Related]
15. The COVID-19 epidemic in Madrid: chronicle of a challenge.
González Del Castillo J; Cánora Lebrato J; Zapatero Gaviria A; Barba Martín R; Prados Roa F; Marco Martínez J
Emergencias; 2020 Jun; 32(3):191-193. PubMed ID: 32395928
[No Abstract] [Full Text] [Related]
16. How to ensure the safety of chemotherapy for advanced cancer patients in the context of new coronavirus?
Yang SF; Qin ZQ; Lu LQ; Yang L; Hong YP
Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13287. PubMed ID: 32991058
[No Abstract] [Full Text] [Related]
17. Immediate Health Surveillance Response to COVID-19 Epidemic.
Croda JHR; Garcia LP
Epidemiol Serv Saude; 2020 Mar; 29(1):e2020002. PubMed ID: 32215535
[No Abstract] [Full Text] [Related]
18. MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions.
Zaller N; Brinkley-Rubinstein L
J Addict Med; 2020 Dec; 14(6):e290-e292. PubMed ID: 33021554
[TBL] [Abstract][Full Text] [Related]
19. On Treatments and Tests Deferred: Preparing for Collateral Damage from COVID-19.
Jain S; Santhosh L
Ann Am Thorac Soc; 2020 Nov; 17(11):1371-1373. PubMed ID: 32667208
[No Abstract] [Full Text] [Related]
20. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
